STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 7, 2026

Jul. 7, 2026

Axe Compute Inc. Joins Russell Microcap® Index, Reflecting Its Growth as a Publicly Traded AI Infrastructure Platform

Indeterminate GlobeNewswire

Jul. 7, 2026

Snail Games Launches ARK: Genesis Part 1 Ascended, ARK Tides of Fortune, and ARK: Dragontopia DLC; $11 Million from Deferred Revenue Backlog to be Recognized in Q3 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Duos Signs Agreement for an Additional 2 MW Deployment

Indeterminate GlobeNewswire

Jul. 7, 2026

Trust Stamp joins the European Union Semiconductor Initiative (IPCEI AST) with the Support of Malta Enterprise

Indeterminate GlobeNewswire

Jul. 7, 2026

Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd

Indeterminate GlobeNewswire

Jul. 7, 2026

House of Doge Issues Mid-2026 Shareholder Letter Highlighting Achievements after Merger and Becoming a Nasdaq-Listed Platform

Indeterminate GlobeNewswire

Jul. 7, 2026

Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling

Indeterminate GlobeNewswire

Jul. 7, 2026

Core AI Holdings Appoints Arie Goor as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 7, 2026

Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program

Indeterminate GlobeNewswire

Jul. 7, 2026

Scality and WEKA deepen partnership to accelerate enterprise AI adoption

Indeterminate GlobeNewswire

Jul. 7, 2026

Pasqal and MegazoneCloud Partner to Bring Industrial-Scale Quantum Computing to South Korea

Indeterminate GlobeNewswire

Jul. 7, 2026

Nu-Tek BioSciences Present Cell Nutrient Innovation, Raw Material Expertise at SIMB 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Nu-Tek BioSciences präsentiert auf der SIMB 2026 Innovationen im Bereich Zellnährstoffe und sein Fachwissen zu Rohstoffen

Indeterminate GlobeNewswire

Jul. 7, 2026

Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

Indeterminate GlobeNewswire

Jul. 7, 2026

Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

Indeterminate GlobeNewswire

Jul. 7, 2026

CoRegen, Inc. Receives FDA Clearance to Advance CRG-150 into Phase 1/2a Clinical Trials, Pioneering a New Frontier in Cell Therapy for Multiple Solid Tumor Types

Indeterminate GlobeNewswire

Jul. 7, 2026

Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Jul. 7, 2026

Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

Indeterminate GlobeNewswire

Jul. 7, 2026

Airia Announces Enhanced Cost Optimization to Give Enterprises Real-Time Control Over AI Spend

Indeterminate GlobeNewswire